Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) [Phase 4]

View source ↗

Summary

A Phase 4 comparative trial evaluating hydrochlorothiazide plus losartan potassium versus amlodipine for essential hypertension has completed (NCT00157963).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Losartan Potassium (Losartan potassium)

Snippet

Sponsor: Organon and Co | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED